Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1971-9-7
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0003-956X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
26
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
575-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:5512155-Adult,
pubmed-meshheading:5512155-Anticonvulsants,
pubmed-meshheading:5512155-Chronic Disease,
pubmed-meshheading:5512155-Epilepsy,
pubmed-meshheading:5512155-Humans,
pubmed-meshheading:5512155-Lupus Erythematosus, Systemic,
pubmed-meshheading:5512155-Male,
pubmed-meshheading:5512155-Time Factors
|
pubmed:articleTitle |
[Chronic lupus erythematosus and antiepileptic treatment].
|
pubmed:publicationType |
Journal Article
|